Common and emerging infectious causes of hematological malignancies in the young

APMIS

Volumn 106, Issue 6, 1998, Pages 585-597

  Lehtinen, Tuula ^a   Lehtinen, Matti ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Childhood; Herpesvirus; Leukemia; Lymphoma; Retrovirus

Indexed keywords

ACUTE LYMPHOCYTIC LEUKEMIA; BURKITT LYMPHOMA; CHILDHOOD LEUKEMIA; EPSTEIN BARR VIRUS; HODGKIN DISEASE; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HUMAN HERPESVIRUS 8; HUMAN T CELL LEUKEMIA VIRUS; PRIORITY JOURNAL; RETROVIRUS; REVIEW;

EID: 0031820528     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1998.tb01388.x     Document Type: Review

References (157)

1. Alero-Thomas, J., Allday, M. & Crawford, D. H.: EBV-associated lymphoproliferative disorders in immunocompromised individuals. Adv. Cancer Res. 55: 329-379, 1990.
2. Alderson, M. R. & Nayak, R.: A study of space time clustering of Hodgkin's disease in the Manchester region. Br. J. Prev. Soc. Med. 25: 168-173, 1971.
3. Alexander, F. E.: Viruses, clusters and clustering of childhood leukaemia. Eur. J. Cancer 29A: 1424-1443, 1993.
4. Alexander, F. E. & Boyle, P.: Comparative study of methodologies for investigating localised clustering of disease. IARC, Lyon 1996.
5. Alexander, F. E., Wray, N., Boyle, P., Bring, J., Coebergh, J. W., Draper, G. et al.: Clustering of childhood leukaemia: a European study in progress. J. Epidem. Biostat. 1: 13-24, 1996.
6. Alexander, F. E., Chan, L. C., Lam, T. H., Yuen, P., Leung, N. K., Ha, S. Y. et al.: Clustering of childhood leukemia in Hong Kong: association with the childhood peak and common acute lymphoblastic leukemia and with population mixing. Br. J. Cancer 75: 457-463, 1997.
7. Ambinder, R. F., Browning, P. J., Lorenziana, I., Leventhal, B. G., Cosenza, H., Mann, R. B. et al.: Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States. Blood 81: 462-467, 1993.
8. Anagnostopoulos, I., Herbst, H., Niedobitek, G. & Stein, H.: Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood 74: 810-819, 1989.
9. Armstrong, A. A., Alexander, F. E., Paes, R. P. et al.: Association of Epstein-Barr virus with pediatric Hodgkin's disease. Am. J. Pathol. 142: 1683-1688, 1993.
10. Aubin, J. T., Poirel, L., Agut, H. et al.: Intrauterine transmission of human herpesvirus 6. Lancet 340: 482, 1992.
11. Bandobashi, K., Daibata, M., Kamioka, M., Tanaka, Y., Kubonishi, I. & Taguchi, H.: Human herpesvirus 6 (HHV-6) - positive Burkitt's lymphoma: Establishment of a novel cell line infected with HHV-6. Blood 90: 1200-1207, 1997.
12. Barriga, F., Kiwanuka, J., Alvarez-Mon, M., Shiramitsu, B., Huber, B., Levine, P. & Magrath, I. T.: Significance of chromosome 8 breakpoint location in Burkitt's lymphoma: Correlation with geographical origin and association with Epstein-Barr virus. CTMI 141: 128-136, 1988.
13. Bithell, J. F., Dutton, S. J., Draper, G. J. & Neary, N. M.: Distribution of childhood leukaemia and non-Hodgkin's lymphomas near nuclear installations in England and Wales. BMJ 309: 501-505, 1994.
14. Bowman, W. P.: A comparative analysis of acute lymphocytic leukaemia in white and black children. In: Magrath, I. T., O'Connor, G. T. & Ramot, B. (Eds.): Pathogenesis of Leukaemias and Lymphomas: Environmental Influences. Raven Press, New York 1984, pp. 169-177.
15. Böni, J., Stalder, J., Reigel, F. & Schüpbach, J.: Detection of reverse transcriptase activity in live attenuated virus vaccines. Clin. Diagn. Virol. 5: 43-53, 1996.
16. Breese Hall, C., Long, C. E., Schnabel, K. C. et al.: Human herpesvirus-6 infection in children. N. Engl. J. Med. 331: 432-438, 1994.
17. Brennan, M., Runanga, J., Barbara, J. A. J., Contreras, M., Tedder, R. S., Garson, J. A. et al.: Prevalence of antibodies to human T cell leukemia lymphoma virus in blood donors in north London. BMJ 307: 1235-1239, 1993.
18. Burkitt, D. P.: A sarcoma involving the jaws in African children. Br. J. Surg. 46: 218-223, 1958.
19. Caron de Fromentel, C. C., May-Levin, F., Mouriesse, H., Lemerle, K., Chandrasekaran, K., May, P.: Presence of circulating antibodies against cellular protein p53 in a notable proportion of children with B-cell lymphoma. Int. J. Cancer 49: 185-189, 1987.
20. Cartwright, R. A., McNully, R. J. Q., Rowland, D. J., Thomas, J., Staines, A. & Stiller, C.: Malignancies in adolescents. In: Cartwright, R. A. et al. (Eds.): The Descriptive Epidemiology of Leukaemia and Related Conditions in Parts of the United Kingdom 1984-1993. The Leukaemia Research Fund, London 1997, pp. 46-56.
21. Chang, Y., Cesarman, E., Pessin, M. S., Frank, L., Culpepper, J., Knowles, D. & Moore, P. S.: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865-1869, 1994.
22. Clark, D. A., Alexander, F. A., McKinney, P. A., Roberts, B. E., O'Brien, C., Jarrett, R. F. et al.: The seroepidemiology of human herpesvirus-6 (HHV-6) from a case-control study of leukaemia and lymphoma. Int. J. Cancer 45: 829-833, 1990.
23. Clark, D. A., Freeland, J. M. L., Mackie, P. L. K., Jarrett, R. F. & Onions, D. E.: Prevalence of antibody to HHV-7 by age. J. Infect. Dis. 168: 251-252, 1993.
24. Cleghorn, F. R., Manns, A., Falk, R., Hange, P., Hanchard, B., Jack, N. et al.: Effect of human T lymphotropic virus type I infection on non-Hodgkin lymphoma incidence. JNCI 87: 1009-1113, 1995.
25. Cline, M. J.: The molecular basis of leukemia. N. Engl. J. Med. 330: 328-336, 1994.
26. Coebergh, J. W., van der Does-van den Berg, A., van Wering, E. R., van Steensel-Moll, H. A., Valkenburg, H. A, van t'Veer, M. B. et al.: Childhood leukemia in the Netherlands, 1973-1986: temporary variation of the incidence of acute lymphocytic leukemia in young children. Br. J. Cancer 59: 100-105, 1989.
27. Correa, P. & O'Connor, G. T.: Epidemiological patterns of Hodgkin's disease. Int. J. Cancer 8: 192-201, 1971.
28. Darby, S. C., Olsen, J. H., Doll, R., Thakrar, B., Brown, P. D., Storm, H. H. et al.: Trends in childhood leukaemia in the Nordic countries in relation to fallout from atmospheric nuclear weapons testing. BMJ 304: 1005-1009, 1992.
29. Dearden, S. B., Taylor, G. M., Gokhale, P. A., Robinson, M. D., Thompson, W., Ollier, W. et al.: Molecular analysis of HLA-DQB alleles in childhood common acute lymphoblastic leukemia. Br. J. Cancer 73: 603-609, 1996.
30. de Campos-Lima, P.-O., Levitckaya, J., Frisan, T. & Masucci, M. G.: Strategies of immuno escape in Epstein-Barr virus persistence and pathogenesis. Sem. Virol. 7: 75-82, 1996.
31. Delaporte, E., Klotz, F., Peeters, M., Martin-Prevel, Y., Bedjabaga, L., Larouze, B. et al.: Non-Hodgkin lymphoma in Gabon and its relation to HTLV-I. Int. J. Cancer 53: 48-50, 1993.
32. de-The, G., Geser, A., Day, N. E., Tukei, P. M. et al.: Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature 274: 756-761, 1978.
33. de-The, G.: Epstein-Barr virus and Burkitt's lymphoma worldwide: the causal relationship revisited. IARC Sci. Publ. 60. Lyon 1985, pp. 165-176.
34. Devesa, S. S., Silverman, D. T. & Young, J. L. Jr.: Cancer incidence and mortality trends among whites in the United States, 1947-84. JNCI 79: 701-745, 1987.
35. Dolcetti, R., Tsancai, B., DeRe, V., Colghini, A., Bigoni, B., Bivetta, B. et al.: Epstein-Barr virus strains with latent membrane protein 1 deletions: prevalence in the Italian population and high association with human immunodeficiency virus-related Hodgkin's disease. Blood 89: 1723-1731, 1997.
36. Doll, R., Evans, H. J. & Darby, S. C.: Paternal exposure not to blame. Nature 367: 678-680, 1994.
37. Dong, X., Hamilton, K. J., Satoh, M. et al.: Initiation of autoimmunity to the p53 tumor suppressor protein by complexes of p53 and SV40 large T antigen. J. Exp. Med. 179: 1243-1252, 1994.
38. Dorak, M. T., Owen, G., Galbraith, I., Henderson, N., Webb, D., Mills, K. I. et al.: Nature of HLA-associateed predisposition to childhood acute lymphoblastic leukemia. Leukemia 9: 875-878, 1995.
39. Dorak, M. T., Mills, K. I., Poynton, C. H. & Burnett, A. K.: HLA and Hodgkin's disease: reply to Taylor and Gokhale. Leukemia 11: 892-893, 1997.
40. Draper, G. J., Kroll, M. E. & Stiller, C. A.: Childhood cancer. Trends in cancer incidence and mortality. In: Doll, R., Fraumeni, J. F. Jr. & Muir, C. S. (Eds.) Cancer Surveys. Spring Harbor Lab. Press, New York, 1994, pp. 493-517.
41. Draper, G. J., Little, M. P., Sorahan, T., Kinlen, L. J., Buntch, K. J., Conquest, A.J. et al.: Cancer in the offspring of radiation workers: A record linkage study. BMJ 315:1181-1193, 1997.
42. Epstein, M. A., Achong, B. G. & Barr, Y. M.: Virus particles in cultured lymphoblasts from Burkitts lymphoma. Lancet i: 702, 1964.
43. Finnish Cancer Registry: Annual report - Cancer Incidence in Finland (1993). Cancer Society of Finland, Publication no. 56, Helsinki 1995.
44. Finnish Cancer Registry: Annual report - Cancer Incidence in Finland (1994). Cancer Society of Finland, Publication no. 57, Helsinki 1996.
45. Finnish Cancer Registry: Annual report - Cancer Incidence in Finland (1995). Cancer Society of Finland, Publication no. 58, Helsinki 1997.
46. Flamand, L., Stefanescu, L, Ablashi, D. V. & Menez, J.: Activation of Epstein-Barr virus cycle by human herpesvirus 6. J. Virol. 67: 6768-6777, 1993.
47. Frenkel, N., Schirmer, E. C., Wyatt, L. S., Kalsafanas, G., Forman, E., Danovich, R. M. & June, C. H.: Isolation of a new herpesvirus from human CD4+ T cells. Proc. Natl. Acad. Sci. USA 87: 748-752, 1990.
48. Frisan, T., Sjöberg, J., Dolcetti, R., Boiocchi, M., De Re, V., Carbone, A. et al.: Local suppression of Epstein-Barr virus (EBV) - specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease. Blood 86: 1493-1501, 1995.
49. Gan, Y.-J., Sullivan, J. L. & Sixbey, J. W.: Detection of cell-free Epstein-Barr virus DNA in serum during acute infectious mononucleosis. J. Infect. Dis. 170: 436-439, 1994.
50. Gardner, M. J., Snee, M. P. & Hall, A. J.: Results of the case-control study of leukaemia and lymphoma among young people near Sellafield nuclear plant in West Cumbria. BMJ 300: 423-429, 1990.
51. George, J.: Childhood hematological malignancies in India. Doctor's Thesis, University of Tampere, Tampere 1997.
52. Geser, A., de-The, G. & Lenoir, G.: Final case reporting from the Ugandan prospective study of the relationship between EBV and Burkitt's lymphoma. Int. J. Cancer 29: 397-400, 1982.
53. Giles, G., Waters, K., Thursfield, V. & Farrugia, H.: Childhood cancer in Victoria, Australia 1970-1989. Int. J. Cancer 63: 794-797, 1995.
54. Gilman, E. A., McNully, R. J. Q., Rowland, D. J., Thomas, J. & Cartwright, R. A.: Space time clustering of acute lymphomablastic leukemia and Hodgkin's disease. In: Cartwright R. A. et al. (Eds.): The Descriptive Epidemiology of Leukemia and Related Conditions in parts of the United Kingdom 1984-1993. The Leukemia Research Fund, London 1997, pp. 71-74.
55. Glass, A. G. & Mantel, N.: Lack of space time clustering of childhood leukemia in Los Angeles County 1960-1964. Cancer Res. 29: 1995-2001, 1969.
56. Goodman, M. T., Yoshizawa, C. N. & Kolonel, L. N.: Ethnic patterns of childhood cancer in Hawaii between 1960-1984. Cancer 64: 1758-1763, 1989.
57. Graeber, T. G., Peterson, J. F., Tsai, M., Monica, K., Fornace, A. J. Jr. & Giaccia, A. J.: Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell. Biol. 14: 6264-6277, 1994.
58. Grässer, F. A., Murray, P. G., Kremmer, E., Klein, K., Remberger, K., Feiden, W. et al.: Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen I (EBNA1): Immunohistologic detection of EBNA1 in malignant cells of Hodgkin's disease. Blood 84: 3792-3798, 1994.
59. Greaves, M. F.: Speculations on the cause of childhood acute lymphoblastic leukaemia. Leukemia 2: 120-125, 1988.
60. Grufferman, S. & Delzell, E.: Epidemiology of Hodgkin's disease. Epidemiol. Rev. 6: 76-106, 1984.
61. Gutierrez, M. I., Bhatia, K., Barriga, F., Diez, B., Muriel, F. S., de Andreas, M. L. et al.: Molecular epidemiology of Burkitt's lymphoma from South America: Differences in breakpoint location and Epstein-Barr virus association from tumors in other world regions. Blood 79: 3261-3266, 1992.
62. Hall, W. W.: Human T cell lymphotrophic virus type I and cutaneous T cell leukaemia/lymphoma. J. Exp. Med. 180: 1581-1585, 1994.
63. Harrington, W. J. Jr., Miller, G. A., Kemper, R. R., Byrne, G. E., Withcomb, C. C. & Rabin, M.: HTLV-I associated leukemia/lymphoma in south Florida. J. Acquir. Immune Defic. Syndr. 4: 284-289, 1991.
64. Hartge, P., Devesa, S. S. & Fraumeni, Jr. J. F.: Hodgkin's and non-Hodgkin's lymphomas. Trends in cancer incidence and mortality. In: Doll, R., Fraumeni, J. F. Jr. & Muir, C. S. (Eds.): Cancer Surveys. Spring Harbor Lab. Press, New York 1994, pp. 423-453.
65. Hartley, A. L., Birch, J. M., McKinney, P. A., Blair, Y., Teare, M. D., Carrette, J. et al.: The Inter-Regional Epidemiological Study of Childhood Cancer (IRESCC): Past medical history in children with cancer. J. Epidemiol. Community Health 42: 235-242, 1988.
66. Hawkins, M. M., Draper, G. J. & Winter, D. L.: Cancer in the offspring of survivors of childhood leukemia and non-Hodgkin lymphomas. Br. J. Cancer 71: 1335-1339, 1995.
67. Henriksson, M. & Luscher, B.: Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res. 68: 109-182, 1996.
68. Heslop, H. E., Brenner, M. K. & Rooney, C. M.: Donor T cell as therapy for EBV lymphoproliferation post bone marrow transplantation. N. Engl. J. Med. 331: 670-680, 1994.
69. Hinuma, Y., Komoda, H., Chosa, T. et al.: Antibodies to adult T-cell leukaemia virus associated antigen (ATLA) in sera from patients with ATL and controls in Japan. A nation-wide sero-epidemiologic study. Int. J. Cancer 29: 631-636, 1982.
70. Höllsberg, P. & Haffler, D. A.: Pathogenesis of diseases induced by human lymphotropic virus type I infection. N. Engl. J. Med. 328: 1173-1182, 1993.
71. Horenstein, M. G., Nador, R. G., Chadburn, A., Hyjek, E. M., Inghirami, G., Knowles, D. M. & Cesarman, E.: Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. Blood 90: 1186-1191, 1997.
72. Horwitz, M.: The genetics of familial leukemia. Leukemia 11: 1347-1359, 1997.
73. Iyengar, S., Levine, P. H., Ablashi, D., Neequaye, J. & Pearson, G. R.: Sero-epidemiological investigations on human herpesvirus 6 (HHV-6) infections using a newly developed early antigen assay. Int. J. Cancer 49: 551-555, 1991.
74. Jain, R., Roncella, S., Hashimoto, S., Carbone, A., Francia di Celle, B., Foa, R. et al.: A potential role for antigen selection in the clonal evolution of Burkitt's lymphoma. J. Immunol. 153: 45-52, 1994.
75. Kinlen, L.: Evidence for an infective cause of childhood leukaemia: Comparison of a Scottish new town with nuclear reprocessing sites in Britain. Lancet ii: 1323-1327, 1988.
76. Kinlen, L. J., Clarke, K. & Hudson, C.: Evidence from population mixing in British New Towns 1946-85 of an infective basis for childhood leukaemia. Lancet 336: 577-582, 1990.
77. Kinlen, L. J. & Petridou, E.: Childhood leukemia and rural population movements: Greece, Italy and other countries. Cancer Causes Control 6: 445-450, 1995.
78. Klein, G. & Klein, E.: Evolution of tumours and the impact of molecular oncology. Nature 315: 190-195, 1985.
79. Krueger, G. R. F., Manak, M., Bourgeois, N. T. et al.: Persistent active herpes virus infection associated with atypical polyclonal lymphoproliferation (APL) and malignant lymphoma. Cancer Res. 49: 1457-1476, 1989.
80. Kvåle, G., Hoiby, E. A. & Pedersen, E.: Hodgkin's disease in patients with previous mononucleosis. Int. J. Cancer 23: 593-597, 1979.
81. Lee, E. S., Locker, J., Nalesnik, M. et al.: The association of EBV with smooth-muscle tumours occurring after organ transplantation. N. Engl. J. Med. 332: 19-25, 1995.
82. Lehtinen, T.: Serologic and flow cytometric DNA studies on the etiopathogenesis of malignant lymphomas. Doctoral Thesis, Univ. of Tampere, Tampere 1989.
83. Lehtinen, M.: Proposal description for a seroepidemiological follow-up study on the etiology of childhood leukaemias and lymphomas. BIOMED-2 Application, Helsinki and Brussels 1995.
84. Lehtinen, T., Isola, J., Aine, R., Alavaikko, M. & Lehtinen, M.: Accumulation of p53 protein correlates with tumour proliferation activity in EBV positive Burkitt's lymphoma. Hematol. Oncol. 10: 273-279, 1992.
85. Lehtinen, T., Lumio, J., Dillner, J., Hakama, M., Knekt, P., Lehtinen, M. et al.: Increased risk of malignant lymphoma indicated by elevated Epstein-Barr virus antibody levels - a prospective study. Cancer Causes Control 4: 187-193, 1993.
86. Lehtinen, T., Luostarinen, T., Dillner, J., Hakama, M., Knekt, P., Lehtinen, M. et al.: Serum p53 accumulation & altered antibody responses to Epstein-Barr virus proteins precede diagnosis of haematopoetic malignancies in the young. Br. J. Haematol. 93: 104-110, 1996.
87. Leinikki, P., Lehtinen, M., Hyöty, H., Parkkonen, P., Kantanen, M.-L. & Hakulinen, J.: Synthetic peptides in diagnostic virology. Adv. Virus Res. 42: 149-186, 1993.
88. Lennette, E. T., Blackburn, D. J. & Levy, A. J.: Antibodies to human herpesvirus 8 in the general population and in Kaposi's sarcoma patients. Lancet 348: 858-861, 1996.
89. Levine, P. H., Manns, A., Jaffe, E. S., Colclough, G., Cavallaro, A., Ready, G. & Blattner, W. A.: The effect of ethnic differences on the pattern of HTLV-I-associated T-cell leukemia/lymphoma (HATL) in the United States. Int. J. Cancer 56: 177-181, 1994.
90. Liebowitz, D.: Epstein-Barr virus - an old dog with new tricks. N. Engl. J. Med. 332: 55-57, 1995.
91. Linde, A., Kallin, B., Dillner, J., Andersson, J., Jägdahl, L., Lindvall, A. & Wahren, B.: Evaluation of enzyme-linked immunosorbent assays with two synthetic peptides of Epstein-Barr virus for diagnosis of infectious mononucleosis. J. Infect. Dis. 767: 903-909, 1990.
92. Löwer, R., Löwer, J., Tardera-Koch, C. & Kurth, R.: A general method for the identification of transcribed retrovirus sequences (R-U5 PCR) reveals the expression of the human endogenous retrovirus loci HERV-H and HERV-K in teratocarcinoma cells. Virology 192: 501-511, 1993.
93. Mack, T. M., Chosen, W., Shibata, D. K., Weiss, L. M., Natwani, B. N., Hernandez, A.M. et al.: Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young adult form of the disease. N. Engl. J. Med. 332: 413-418, 1995.
94. MacMahon, B.: Epidemiological evidence on the nature of Hodgkin's disease. Cancer 10: 1045-1054, 1957.
95. MacMahon, B.: Epidemiology of Hodgkin's disease. Cancer Res. 26: 1189-1200, 1966.
96. MacMahon, B.: Is acute lymphoblastic leukaemia in children virus-related? Am J. Epidemiol. 136: 916-924, 1992.
97. MacMahon, B. & Newill, F. A.: Birth characteristics of children dying of malignant neoplasms. JNCI 28: 231-244, 1962.
98. Magrath, I. T.: The pathogenesis of Burkitt's lymphoma. Adv. Cancer Res. 53: 133-165, 1990.
99. Manning, M. D. & Carroll, B. E.: Some epidemiological aspects of leukemia in children. JNCI 28: 231-244, 1957.
100. McClain, K. L., Leach, C. T., Jenson, H. B., Joshi, V. V., Pollock, B. H., Parmley, R.T. et al.: Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS. N. Engl. J. Med. 332: 1-8, 1995.
101. McCredie, M., Hoyer, A., Coates, M., & Taylor, R.: Trends in Cancer Incidence and Mortality in New South Wales 1972-1989. New South Wales Central Cancer Registry, Woolloomooloo 1992.
102. McKinney, P. A., Cartwright, R. A., Saiu, J. M. T., Mann, J. R., Stiller, C. A., Draper, G. J. & Hartley, A. L.: The inter-regional epidemiological study of childhood cancers (IRESCC): a case-control study of aetiological factors in leukaemia and lymphoma. Arch. Dis. Child. 62: 279-287, 1987.
103. McWhirter, W. R. & Bacon, J. E.: Epidemiology of acute lymphoblastic leukemia of childhood in Brisbane. Med. J. Aust. 2: 144-145, 1980.
104. Memon, A. & Doll, R.: A search for unknown blood-borne oncogenic virus (unpublished).
105. Miller, B. A., Ries, L. A. G. & Hankey, B. F.: SEER Cancer Statistics Review: 1973-1990. National Cancer Institute. NIH Pub. no. 93-2789, USA 1993.
106. Morente, M. M., Piris, M. A., Abraira, V., Acevedo, A., Aguilera, B., Bellas, C. et al.: Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high KI-67 proliferation index and absence of Epstein-Barr virus latent membrane protein 1 expression. Blood 90: 2429-2436, 1997.
107. Mueller, N., Evans, A., Harris, N. L., Comstock, G. W., Jellum, E., Magnus, K. et al.: Hodgkin's disease and Epstein-Barr virus. N. Engl. J. Med. 320: 689-695, 1989.
108. Muirhead, C. R.: Childhood leukemia in metropolitan regions in the United States: a possible relation to population density? Cancer Causes Control 6: 383-388, 1995.
109. Nandakumar, A., Anantha, N., Appaji, S. L., Swamy, K., Mukherjee, G., Venugopal, T., Reddy, S. & Dhar, M.: Descriptive epidemiology of childhood cancers in Bangalore, India. Cancer Causes Control 7: 405-410, 1996.
110. Niedobitek, G., Agathanggelou, A., Rowe, M., Jones, E. L., Jones, D. B., Turyaguma, P. et al.: Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma. Blood 86: 659-667, 1995.
111. Niedobitek, G., Kremmer, E., Herbst, H., Whitehead, L., Dawson, C. B., Niedobitek, E. et al.: Immunohistochemical detection of Epstein-Barr virus encoded latent membrane protein 2A in Hodgkin's disease and infectious mononucleosis. Blood 90: 1664-1672, 1997.
112. NOPHO: Childhood Cancer in the Nordic Countries. Report on Epidemiology and Therapeutic Results from Registries and Working Groups, Kuopio 1997.
113. Osman, H. K.: Doctoral Thesis, University of London, London 1994.
114. Paavonen, J., Lähdeaho, M.-L., Puolakkainen, M., Mäki, M., Parkkonen, P. & Lehtinen, M.: Antibody response to B cell epitopes of Chlamydia trachomatis 60-kDa heat-shock protein and corresponding mycobacterial and human peptides in infants with chlamydial pneumonitis. J. Infect. Dis. 169: 908-911, 1994.
115. Pallesen, G., Hamilton-Dutoit, S. J., Rowe, M. & Young, L. S.: Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 337: 320-322, 1991.
116. Pallesen, G., Hamilton-Dutoit, S. J. & Zhou, X.: The association of Epstein-Barr virus (EBV) with T cell lymphoproliferations and Hodgkin's disease: Two new developments in the field. Adv. Cancer Res. 62: 179-239, 1993.
117. Parkin, D. M., Stiller, C. A. & Draper, G. J. (Eds.): International Incidence of Childhood Cancer. IARC Sci. Publ. no. 87, Lyon 1988.
118. Parsonnet, J., Hansen, S., Rodriguez, L., Gelb, A. B., Warnke, R. A., Jellum, E. et al.: Helicobacter pylori infection and gastric lymphoma. N. Engl. J. Med. 330: 1267-1271, 1994.
119. Petridou, E., Kassimos, D. & Kalmanti, M.: Age of exposure to infections and risk of childhood leukaemia. BMJ 307: 774, 1993.
120. Petridou, E., Revinthi, K., Alexander, F. E. et al.: Space-time clustering of childhood leukaemia in Greece. Evidence supporting a viral aetiology. Br. J. Cancer 73: 1278-1283, 1996.
121. Polednak, A. P.: Trends in cancer incidence in Connecticut, 1935-1991. Cancer 74: 2863-2872, 1994.
122. Pyra, H., Böni, J. & Schupbach, J.: Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement. Proc. Natl. Acad. Sci. USA 91: 1544-1548, 1993.
123. Quintanilla-Martinez, L., Lome-Maldonado, C., Pott, G., Gschwendtner, A., Grettler, E., Reyes, E. et al.: Primary non-Hodgkin's lymphoma of the intestine: high prevalence of Epstein-Barr virus in Mexican lymphomas as compared to European cases. Blood 89: 644-651, 1997.
124. Rabkin, C. S., Hilgartner, M. W. & Hedberg, K. W.: Incidence of lymphomas and other cancers in HIV-infected and HIV-uninfected patients with hemophilia. JAMA 267: 1090-1094, 1992.
125. Razzouk, B. I., Shrinivas, S., Sample, C. E., Singh, V. & Sixbey, J. W.: Epstein-Barr virus DNA recombination and loss in sporadic Burkitt's lymphoma. J. Infect. Dis. 773: 529-535, 1996.
126. Ries, L. A. G., Miller, B. A., Hankey, B. F., Kosary, C. L., Harras, A. & Edwards, B. K.: SEER cancer statistics review. 1973-1991: Tables and graphs. Bethesda, MD, NCI (NIH Publication no. 94-2789, USA 1994).
127. Roman, E., Watson, A. & Beral, V.: Case-control study of leukaemia and non-Hodgkin's lymphoma among children aged 0-4 years living in West Berkshire and North Hampshire health districts. BMJ 306: 615-621, 1993.
128. Rooney, C. M., Smith, C. A., Ng, C. Y. et al.: Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 345: 9-13, 1995.
129. Rosdahl, N., Larsen, S. O. & Clemmesen, J.: Hodgkin's disease in patients with previous infectious mononucleosis. BMJ 288: 253-256, 1974.
130. Sandlund, J. T., Downing, J. R. & Crist, W. M.: Non-Hodgkin's lymphoma in childhood. N. Engl. J. Med. 334: 1238-1248, 1996.
131. Sandlund, J. T., Fonseca, T., Leimig, T., Verissimo, L., Ribeiro, R., Lira, V. et al.: Predominance and characteristics of Burkitt's lymphoma among children with non-Hodgkin's lymphoma in northeastern Brazil. Leukemia 11: 743-746, 1997.
132. Secchiero, P., Carrigan, D. R., Asano, Y. et al.: Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J. Infect. Dis. 171: 273-280, 1995.
133. Shankar, A. G., Ashley, S., Radford, M., Barrett, A., Wright, D. & Pinkerton, C. R.: Does histology influence outcome in childhood Hodgkin's disease? Results from the United Kingdom Childrens Cancer Study Group. J. Clin. Oncol. 15: 2622-2630, 1997.
134. Shimkin, M. B.: Classics of experimental oncology. NIH Publication no. 80-2150: 328-360, 1980.
135. Shu, X.-O., Ross, J. A., Pendergraxs, T. W. et al.: Parental alcohol consumption, cigarette smoking and risk of infant leukemia. JNCI 88: 24-31, 1996.
136. Smith, M.: Considerations on the possible viral etiology for B-precursor acute lymphoblastic leukaemia of childhood. J. Immunother. 20: 89-100, 1997.
137. Snow, E. C.: The role of c-myc during normal B cell proliferation, and as B cells undergo malignant transformation. CTMI 224: 211-220, 1996.
138. Söderlund, M., Braun, C. S., Cohen, B. J. & Hedman, K.: Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity. J. Infect. Dis. 171: 710-713, 1995.
139. Spitz, M. R., Sider, J. G., Johnson, C. C., Butler, J. J., Pollack, E. S. & Newell, G. R.: Ethnic patterns of Hodgkin's disease incidence among children and adolescents in the United States 1973-1982. JNCI 76: 235-239, 1986.
140. Stewart, A., Webb, J. & Hewitt, D.: A survey of childhood malignancies. BMJ 1: 1495-1508, 1958.
141. Stiller, C. A. & Parkin, D. M.: International incidence of childhood lymphomas. Paediatr. Perinat. Epidemiol. 4: 302-324, 1990.
142. Szekely, L., Selivanova, G., Magnusson, K. P., Klein, G. & Wiman, K.: EBNA5, an Epstein-Barr virus-encoded nuclear antigen binds to the retinoblastoma and p53 proteins. Proc. Natl. Acad. Sci. USA 90: 5455-5459, 1993.
143. Szekely, L., Jiang W.-O., Pokrovskaja, K., Wiman, K. G., Klein, G. & Ringertz, N.: Reversible nucleolar translocation of EBV encoded EBNA-5 and Hsp70 proteins after exposure to heat shock or cell density congestion. J. Gen. Virol. 76: 2423-2432, 1995.
144. Tanaka-Taya, K., Kondo, T., Mukai, T., Miyoshi, H., Yamamoto, Y., Okada, S. & Yamanishi, K.: Seroepidemiological study of human herpesvirus-6 and -7 in children of different ages and detection of these two viruses in throat swabs by poly merase chain reaction. J. Med. Virol. 48: 88-94, 1996.
145. Taylor, G. M., Gokhale, T. A., Crowther, D., Woll, P., Harris, M., Alexander, F. et al.: Increased frequency of HLA-DPB1*0301 in Hodgkin's disease suggests that susceptibility is HVR-sequence and subtype associated. Leukemia 10: 854-859, 1996.
146. Tedeschi, R., Foong, Y. T., Cheng, H. M., dePaoli, P., Lehtinen, T., Elfborg, T. & Dillner, J.: The disease associations of the antibody response against the Epstein-Barr virus transactivator protein ZEBRA can be separated into different epitopes. J. Gen. Virol. 76: 1393-1400, 1995.
147. Torelli, G., Marasca, R., Luppi, M., Selleri, L., Ferrari, S., Narni, F. et al.: Human herpesvirus 6 in human lymphomas: Identification of specific sequences in Hodgkin's lymphomas by polymerase chain reaction. Blood 77: 2251-2257, 1991.
148. van Hoff, J., Schymura, M. & Curnen, M. G. M.: Trends in incidence of childhood and adolescent cancer in Connecticut, 1935 - 1979. Med. Pediatr. Oncol. 16: 78-87, 1988.
149. Vienna, N. J., Greenwald, P. & Davies, J. N. P.: Nature of Hodgkin's disease agent. Lancet i: 733-736, 1971.
150. Wada, M., Nartram, C. R., Nakamura, H., Hachiya, M., Chen, D.-L., Borenstein, J. et al.: Analysis of p53 mutations in a large series of lymphoid hematological malignancies of childhood. Blood 82: 3163-3169, 1993.
151. Weiss, L. M., Movahed, L. A., Warnke, R. A. & Sklar, J.: Detection of Epstein-Barr virus genomes in Reed-Sternberg cells of Hodgkin's disease. N. Engl. J. Med. 320: 502-505, 1989.
152. Westergaard, T., Melbye, M., Pedersen, J. B., Frisch, M., Olsen, J. H. & Andersen, P.K.: Birth order, sibship size and risk of Hodgkin's disease in children and young adults: a population based study of 31 million person-years. Int. J. Cancer 72: 977-981, 1997.
153. Witherell, H. L., Hansen, S., Jellum, E., Orentreich, N., Vogelman, J. H. & Parsonnet, J.: Risk for gastric lymphoma in persons with CagA+ and CagA- Helicobacter pylori infection. J. Infect. Dis. 176: 1641-1644, 1997.
154. Wu, T.-C., Mann, R. B., Charache, P., Hayward, S. D., Staal, S., Lambe, B. C. & Ambinder, R. F.: Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease. Int. J. Cancer 46: 801-806, 1990.
155. Yamanishi, K., Okuno, T., Shiraki, K., Takahashi, M., Kondo, T., Asano, Y. & Kurata, T.: Identification of human herpesvirus 6 as a causal agent for exanthema subitum. Lancet i: 1065-1067, 1988.
156. Yao, Q. Y., Tiernay, R. J., Croom-Carter, D., Cooper, G. M., Ellis, C. J., Rowe, M. & Rickinson, A. B.: Isolation of intertypic recombinants of Epstein-Barr virus from T-cell-immunocompromised individuals. J. Virol. 70: 4895-4903, 1996a.
157. Yao, Q. Y., Tiernay, R. J., Croom-Carter, D., Dukers, D., Cooper, G. M., Ellis, C. J. et al.: Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals. J. Virol. 70: 4884-4894, 1996b.